BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22075555)

  • 1. Genetically modified T cells targeting interleukin-11 receptor α-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases.
    Huang G; Yu L; Cooper LJ; Hollomon M; Huls H; Kleinerman ES
    Cancer Res; 2012 Jan; 72(1):271-81. PubMed ID: 22075555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples.
    Lewis VO; Ozawa MG; Deavers MT; Wang G; Shintani T; Arap W; Pasqualini R
    Cancer Res; 2009 Mar; 69(5):1995-9. PubMed ID: 19244100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation.
    Lewis VO; Devarajan E; Cardó-Vila M; Thomas DG; Kleinerman ES; Marchiò S; Sidman RL; Pasqualini R; Arap W
    Proc Natl Acad Sci U S A; 2017 Jul; 114(30):8065-8070. PubMed ID: 28698375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-11 receptor α is overexpressed in human osteosarcoma, and near-infrared-labeled IL-11Rα imaging agent could detect osteosarcoma in mouse tumor xenografts.
    Liu T; Ma Q; Zhang Y; Ke S; Yan K; Chen X; Wen Y; Fan Q; Qiu X
    Tumour Biol; 2015 Apr; 36(4):2369-75. PubMed ID: 25524575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD166/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma.
    Wang Y; Yu W; Zhu J; Wang J; Xia K; Liang C; Tao H
    J Exp Clin Cancer Res; 2019 Apr; 38(1):168. PubMed ID: 30995926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-11 receptor alpha is expressed on canine osteosarcoma.
    Sottnik JL; Thamm DH
    Vet Comp Oncol; 2010 Jun; 8(2):96-102. PubMed ID: 20579322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis.
    Guma SR; Lee DA; Yu L; Gordon N; Hughes D; Stewart J; Wang WL; Kleinerman ES
    Pediatr Blood Cancer; 2014 Apr; 61(4):618-26. PubMed ID: 24136885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-11Rα: a novel target for the treatment of osteosarcoma.
    Lewis VO
    Adv Exp Med Biol; 2014; 804():285-9. PubMed ID: 24924180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells.
    Talbot LJ; Chabot A; Funk A; Nguyen P; Wagner J; Ross A; Tillman H; Davidoff A; Gottschalk S; DeRenzo C
    Front Immunol; 2021; 12():691741. PubMed ID: 34211478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord blood.
    Huls MH; Figliola MJ; Dawson MJ; Olivares S; Kebriaei P; Shpall EJ; Champlin RE; Singh H; Cooper LJ
    J Vis Exp; 2013 Feb; (72):e50070. PubMed ID: 23407473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas.
    Huang X; Park H; Greene J; Pao J; Mulvey E; Zhou SX; Albert CM; Moy F; Sachdev D; Yee D; Rader C; Hamby CV; Loeb DM; Cairo MS; Zhou X
    PLoS One; 2015; 10(7):e0133152. PubMed ID: 26173023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases.
    Dow S; Elmslie R; Kurzman I; MacEwen G; Pericle F; Liggitt D
    Hum Gene Ther; 2005 Aug; 16(8):937-46. PubMed ID: 16076252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of human osteosarcoma cell lines with high metastatic potential to lungs and their utilities for therapeutic studies on metastatic osteosarcoma.
    Kimura K; Nakano T; Park YB; Tani M; Tsuda H; Beppu Y; Moriya H; Yokota J
    Clin Exp Metastasis; 2002; 19(6):477-85. PubMed ID: 12405284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells.
    Kiessling S; Muller-Newen G; Leeb SN; Hausmann M; Rath HC; Strater J; Spottl T; Schlottmann K; Grossmann J; Montero-Julian FA; Scholmerich J; Andus T; Buschauer A; Heinrich PC; Rogler G
    J Biol Chem; 2004 Mar; 279(11):10304-15. PubMed ID: 14701802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-11Rα-targeted nanostrategy empowers chemotherapy of relapsed and patient-derived osteosarcoma.
    Jiang J; Wang R; Yang L; Sha Y; Zhao S; Guo J; Chen D; Zhong Z; Meng F
    J Control Release; 2022 Oct; 350():460-470. PubMed ID: 36041590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
    Koshkina N; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of the extracellular domains of human interleukin 11α receptor reveals mechanisms of cytokine engagement.
    Metcalfe RD; Aizel K; Zlatic CO; Nguyen PM; Morton CJ; Lio DS; Cheng HC; Dobson RCJ; Parker MW; Gooley PR; Putoczki TL; Griffin MDW
    J Biol Chem; 2020 Jun; 295(24):8285-8301. PubMed ID: 32332100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A designer hyper interleukin 11 (H11) is a biologically active cytokine.
    Dams-Kozlowska H; Gryska K; Kwiatkowska-Borowczyk E; Izycki D; Rose-John S; Mackiewicz A
    BMC Biotechnol; 2012 Mar; 12():8. PubMed ID: 22433466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against the human interleukin-11 receptor alpha-chain (IL-11Ralpha) and their use in studies of human mononuclear cells.
    Blanc C; Vusio P; Schleinkofer K; Boisteau O; Pflanz S; Minvielle S; Grötzinger J; Müller-Newen G; Heinrich PC; Jacques Y; Montero-Julian FA
    J Immunol Methods; 2000 Jul; 241(1-2):43-59. PubMed ID: 10915848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by interleukin-18 of the growth of Dunn osteosarcoma cells.
    Okamoto T; Yamada N; Tsujimura T; Sugihara A; Nishizawa Y; Ueda H; Kashiwamura S; Tsutsui H; Futani H; Maruo S; Okamura H; Terada N
    J Interferon Cytokine Res; 2004 Mar; 24(3):161-7. PubMed ID: 15035849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.